Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.

Winer RL, Lin J, Tiro JA, Miglioretti DL, Beatty T, Gao H, Kimbel K, Thayer C, Buist DSM.

JAMA Netw Open. 2019 Nov 1;2(11):e1914729. doi: 10.1001/jamanetworkopen.2019.14729.

PMID:
31693128
2.

Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer.

Brandt KR, Scott CG, Miglioretti DL, Jensen MR, Mahmoudzadeh AP, Hruska C, Ma L, Wu FF, Cummings SR, Norman AD, Engmann NJ, Shepherd JA, Winham SJ, Kerlikowske K, Vachon CM.

Breast Cancer Res. 2019 Oct 28;21(1):118. doi: 10.1186/s13058-019-1198-9.

3.

A Scalable Database of Organ Doses for Common Diagnostic Fluoroscopy Procedures of Children: Procedures of Historical Practice for Use in Radiation Epidemiology Studies.

Marshall EL, Rajderkar D, Brown JL, Stepusin EJ, Borrego D, Duncan J, Sammet CL, Munneke JR, Kwan ML, Miglioretti DL, Smith-Bindman R, Bolch WE.

Radiat Res. 2019 Oct 14. doi: 10.1667/RR15445.1. [Epub ahead of print]

PMID:
31609677
4.

Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age.

Demb J, Abraham L, Miglioretti DL, Sprague BL, O'Meara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D.

J Natl Cancer Inst. 2019 Sep 6. pii: djz172. doi: 10.1093/jnci/djz172. [Epub ahead of print]

PMID:
31593591
5.

Analysis of Computed Tomography Radiation Doses Used for Lung Cancer Screening Scans.

Demb J, Chu P, Yu S, Whitebird R, Solberg L, Miglioretti DL, Smith-Bindman R.

JAMA Intern Med. 2019 Sep 23. doi: 10.1001/jamainternmed.2019.3893. [Epub ahead of print]

PMID:
31545340
6.

Fear of cancer recurrence and associations with mental health status and individual characteristics among cancer survivors: Findings from a nationally representative sample.

Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG.

J Psychosoc Oncol. 2019 Sep 11:1-18. doi: 10.1080/07347332.2019.1649338. [Epub ahead of print]

PMID:
31510882
7.

Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States.

Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, Conant EF, Hampton JM, Huang H, Kerlikowske K, Lee SJ, Miglioretti DL, Sprague BL, Tosteson ANA, Yaffe M, Stout NK.

J Natl Cancer Inst. 2019 Sep 10. pii: djz184. doi: 10.1093/jnci/djz184. [Epub ahead of print]

PMID:
31503283
8.

Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016.

Smith-Bindman R, Kwan ML, Marlow EC, Theis MK, Bolch W, Cheng SY, Bowles EJA, Duncan JR, Greenlee RT, Kushi LH, Pole JD, Rahm AK, Stout NK, Weinmann S, Miglioretti DL.

JAMA. 2019 Sep 3;322(9):843-856. doi: 10.1001/jama.2019.11456.

PMID:
31479136
9.

Joint Indirect Standardization when Only Marginal Distributions are Observed in the Index Population.

Wang Y, Tancredi DJ, Miglioretti DL.

J Am Stat Assoc. 2019;114(526):622-630. doi: 10.1080/01621459.2018.1506340. Epub 2018 Oct 29.

PMID:
31452558
10.

Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.

Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ.

J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13.

PMID:
31410813
11.

Cognitive effort decreases beta, alpha, and theta coherence and ends afterdischarges in human brain.

Lesser RP, Webber WRS, Miglioretti DL, Pillai JJ, Agarwal S, Mori S, Morrison PF, Castagnola S, Lawal A, Lesser HJ.

Clin Neurophysiol. 2019 Nov;130(11):2169-2181. doi: 10.1016/j.clinph.2019.07.007. Epub 2019 Jul 19.

PMID:
31399356
12.

Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women.

Buist DSM, Tiro JA, Thayer C, Beatty T, Miglioretti DL, Lin J, Winer RL.

Contemp Clin Trials Commun. 2019 Jul 19;15:100413. doi: 10.1016/j.conctc.2019.100413. eCollection 2019 Sep.

13.

Trends in Medical Imaging During Pregnancy in the United States and Ontario, Canada, 1996 to 2016.

Kwan ML, Miglioretti DL, Marlow EC, Aiello Bowles EJ, Weinmann S, Cheng SY, Deosaransingh KA, Chavan P, Moy LM, Bolch WE, Duncan JR, Greenlee RT, Kushi LH, Pole JD, Rahm AK, Stout NK, Smith-Bindman R; Radiation-Induced Cancers Study Team.

JAMA Netw Open. 2019 Jul 3;2(7):e197249. doi: 10.1001/jamanetworkopen.2019.7249.

14.

Methods for the Watch the Spot Trial: A Pragmatic Trial of More vs. Less Intensive Strategies for Active Surveillance of Small Pulmonary Nodules.

Gould MK, Smith-Bindman R, Kelly K, Altman DE, Barjaktarevic I, Creekmur B, de Bie E, Dyer DS, Mortani Barbosa EJ Jr, Mularski RA, Qi L, Vaszar LT, Yu S, Miglioretti DL; Watch the Spot Trial Investigators .

Ann Am Thorac Soc. 2019 Jul 17. doi: 10.1513/AnnalsATS.201903-268SD. [Epub ahead of print]

PMID:
31314549
15.

Corrigendum to "Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system" [Contemp. Clin. Trials 64 (2018) 77-87].

Winer R, Tiro JA, Miglioretti DL, Thayer C, Beatty T, Lin J, Gao H, Kimbel K, Buist DSM.

Contemp Clin Trials. 2019 Sep;84:105811. doi: 10.1016/j.cct.2019.07.003. Epub 2019 Jul 13. No abstract available.

PMID:
31307906
16.

Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging.

Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, O'Meara ES, Miglioretti DL.

JAMA Intern Med. 2019 Jul 1. doi: 10.1001/jamainternmed.2019.1758. [Epub ahead of print]

PMID:
31260054
17.

Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition.

Engmann NJ, Scott C, Jensen MR, Winham SJ, Ma L, Brandt KR, Mahmoudzadeh A, Whaley DH, Hruska CB, Wu FF, Norman AD, Hiatt RA, Heine J, Shepherd J, Pankratz VS, Miglioretti DL, Kerlikowske K, Vachon CM.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1324-1330. doi: 10.1158/1055-9965.EPI-18-1375. Epub 2019 Jun 11.

PMID:
31186265
18.

Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer.

Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL.

Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4.

19.

Lack of Standardized Terminology in Ultrasound Reports for Ovarian Cysts-Reply.

Smith-Bindman R, Miglioretti D.

JAMA Intern Med. 2019 Jun 1;179(6):848-849. doi: 10.1001/jamainternmed.2019.0976. No abstract available.

PMID:
31157851
20.

Discussions of Dense Breasts, Breast Cancer Risk, and Screening Choices in 2019.

Kerlikowske K, Miglioretti DL, Vachon CM.

JAMA. 2019 Jul 2;322(1):69-70. doi: 10.1001/jama.2019.6247. No abstract available.

PMID:
31150040
21.

Combined effect of volumetric breast density and body mass index on breast cancer risk.

Engmann NJ, Scott CG, Jensen MR, Winham S, Miglioretti DL, Ma L, Brandt K, Mahmoudzadeh A, Whaley DH, Hruska C, Wu F, Norman AD, Hiatt RA, Heine J, Shepherd J, Pankratz VS, Vachon CM, Kerlikowske K.

Breast Cancer Res Treat. 2019 Aug;177(1):165-173. doi: 10.1007/s10549-019-05283-z. Epub 2019 May 25.

PMID:
31129803
22.

Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network.

Doria-Rose VP, Greenlee RT, Buist DSM, Miglioretti DL, Corley DA, Brown JS, Clancy HA, Tuzzio L, Moy LM, Hornbrook MC, Brown ML, Ritzwoller DP, Kushi LH, Greene SM.

EGEMS (Wash DC). 2019 Mar 29;7(1):7. doi: 10.5334/egems.273. Review.

23.

Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.

Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL.

JAMA Intern Med. 2019 May 1;179(5):658-667. doi: 10.1001/jamainternmed.2018.8372. Erratum in: JAMA Intern Med. 2019 Apr 29;:.

PMID:
30882843
24.

Relationships Between Fear of Cancer Recurrence and Lifestyle Factors Among Cancer Survivors.

Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG.

J Cancer Educ. 2019 Mar 16. doi: 10.1007/s13187-019-01509-2. [Epub ahead of print]

PMID:
30879181
25.

Digital Breast Tomosynthesis: Radiologist Learning Curve.

Miglioretti DL, Abraham L, Lee CI, Buist DSM, Herschorn SD, Sprague BL, Henderson LM, Tosteson ANA, Kerlikowske K; Breast Cancer Surveillance Consortium.

Radiology. 2019 Apr;291(1):34-42. doi: 10.1148/radiol.2019182305. Epub 2019 Feb 26.

PMID:
30806595
26.

Validation of the breast cancer surveillance consortium model of breast cancer risk.

Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, Kerlikowske K.

Breast Cancer Res Treat. 2019 Jun;175(2):519-523. doi: 10.1007/s10549-019-05167-2. Epub 2019 Feb 22.

PMID:
30796654
27.

Re: "Linkage of the ACR National Mammography Database to the Network of State Cancer Registries: Proof of Concept Evaluation by the ACR National Mammography Database Committee".

Miglioretti DL, Lee JM, Kerlikowske K; Breast Cancer Surveillance Consortium.

J Am Coll Radiol. 2019 Feb;16(2):135-136. doi: 10.1016/j.jacr.2018.09.056. No abstract available.

PMID:
30717832
28.

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.

Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K.

J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.

PMID:
30625040
29.

Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium.

Sprague BL, Kerlikowske K, Bowles EJA, Rauscher GH, Lee CI, Tosteson ANA, Miglioretti DL.

J Natl Cancer Inst. 2019 Jan 8. doi: 10.1093/jnci/djy210. [Epub ahead of print]

PMID:
30624682
30.

International variation in radiation dose for computed tomography examinations: prospective cohort study.

Smith-Bindman R, Wang Y, Chu P, Chung R, Einstein AJ, Balcombe J, Cocker M, Das M, Delman BN, Flynn M, Gould R, Lee RK, Yellen-Nelson T, Schindera S, Seibert A, Starkey J, Suntharalingam S, Wetter A, Wildberger JE, Miglioretti DL.

BMJ. 2019 Jan 2;364:k4931. doi: 10.1136/bmj.k4931.

31.

Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.

Tiro JA, Betts AC, Kimbel K, Buist DSM, Mao C, Gao H, Shulman L, Malone C, Beatty T, Lin J, Thayer C, Miglioretti DL, Winer RL.

J Womens Health (Larchmt). 2019 Mar;28(3):384-392. doi: 10.1089/jwh.2018.7070. Epub 2018 Nov 27.

PMID:
30481121
32.

Risk of Malignant Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population.

Smith-Bindman R, Poder L, Johnson E, Miglioretti DL.

JAMA Intern Med. 2019 Jan 1;179(1):71-77. doi: 10.1001/jamainternmed.2018.5113.

33.

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.

Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL.

AJR Am J Roentgenol. 2018 Nov;211(5):957-963. doi: 10.2214/AJR.17.19350. Epub 2018 Sep 20.

34.

Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography.

Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA.

J Clin Oncol. 2018 Jul 10;36(20):2070-2077. doi: 10.1200/JCO.2017.76.8267. Epub 2018 May 2.

35.

National Institutes of Health Pathways to Prevention Workshop: Methods for Evaluating Natural Experiments in Obesity.

Emmons KM, Doubeni CA, Fernandez ME, Miglioretti DL, Samet JM.

Ann Intern Med. 2018 Jun 5;168(11):809-814. doi: 10.7326/M18-0501. Epub 2018 May 1.

PMID:
29710235
36.

Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.

Kerlikowske K, Scott CG, Mahmoudzadeh AP, Ma L, Winham S, Jensen MR, Wu FF, Malkov S, Pankratz VS, Cummings SR, Shepherd JA, Brandt KR, Miglioretti DL, Vachon CM.

Ann Intern Med. 2018 Jun 5;168(11):757-765. doi: 10.7326/M17-3008. Epub 2018 May 1.

37.

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Mandelblatt JS, Near AM, Miglioretti DL, Munoz D, Sprague BL, Trentham-Dietz A, Gangnon R, Kurian AW, Weedon-Fekjaer H, Cronin KA, Plevritis SK.

Med Decis Making. 2018 Apr;38(1_suppl):9S-23S. doi: 10.1177/0272989X17700624.

38.

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642.

39.

Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.

Winer RL, Tiro JA, Miglioretti DL, Thayer C, Beatty T, Lin J, Gao H, Kimbel K, Buist DSM.

Contemp Clin Trials. 2018 Jan;64:77-87. doi: 10.1016/j.cct.2017.11.004. Epub 2017 Nov 4. Erratum in: Contemp Clin Trials. 2019 Sep;84:105811.

40.

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. doi: 10.1158/1055-9965.EPI-17-0531. Epub 2017 Oct 6.

41.

Combining quantitative and qualitative breast density measures to assess breast cancer risk.

Kerlikowske K, Ma L, Scott CG, Mahmoudzadeh AP, Jensen MR, Sprague BL, Henderson LM, Pankratz VS, Cummings SR, Miglioretti DL, Vachon CM, Shepherd JA.

Breast Cancer Res. 2017 Aug 22;19(1):97. doi: 10.1186/s13058-017-0887-5.

42.

Mammography Performance Benchmarks in an Era of Value-based Care.

Lee JM, Miglioretti DL, Burnside ES, Morris EA, Smith RA, Lehman CD.

Radiology. 2017 Aug;284(2):605-607. doi: 10.1148/radiol.2017170638. No abstract available.

43.

Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.

44.

Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice.

Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K.

Acad Radiol. 2017 Oct;24(10):1256-1264. doi: 10.1016/j.acra.2017.03.016. Epub 2017 May 24.

45.

Optimizing Radiation Doses for Computed Tomography Across Institutions: Dose Auditing and Best Practices.

Demb J, Chu P, Nelson T, Hall D, Seibert A, Lamba R, Boone J, Krishnam M, Cagnon C, Bostani M, Gould R, Miglioretti D, Smith-Bindman R.

JAMA Intern Med. 2017 Jun 1;177(6):810-817. doi: 10.1001/jamainternmed.2017.0445.

46.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

47.

Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Oncol. 2017 Sep 1;3(9):1228-1236. doi: 10.1001/jamaoncol.2016.6326. Erratum in: JAMA Oncol. 2019 Sep 26;:.

48.

Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.

Engmann NJ, Scott CG, Jensen MR, Ma L, Brandt KR, Mahmoudzadeh AP, Malkov S, Whaley DH, Hruska CB, Wu FF, Winham SJ, Miglioretti DL, Norman AD, Heine JJ, Shepherd J, Pankratz VS, Vachon CM, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):930-937. doi: 10.1158/1055-9965.EPI-16-0882. Epub 2017 Feb 1.

49.

Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.

Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):938-944. doi: 10.1158/1055-9965.EPI-16-0801. Epub 2017 Jan 17.

50.

Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.

Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL; Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2016 Dec 31;109(5). doi: 10.1093/jnci/djw276. Print 2017 May.

Supplemental Content

Loading ...
Support Center